Johnson & Johnson beats by $0.02, beats on revs; raises FY18 outlook
- Reports Q3 (Sep) earnings of $2.05 per share, $0.02 better than the S&P Capital IQ Consensus of $2.03; revenues rose 3.6% year/year to $20.35 bln vs the $20.05 bln S&P Capital IQ Consensus.
- Co raises guidance for FY18, sees EPS of $8.13-8.18 vs. $8.15 S&P Capital IQ Consensus, and compared to $8.07-8.17 prior; sees FY18 revs of $81.0-81.4 bln vs. $81.26 bln S&P Capital IQ Consensus, and compared to $80.5-81.3 bln prior.